相关实验视频

Updated: May 31, 2025

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

13.7K

血栓生成和埃米齐祖马布水平之间没有相关性:对监测埃米齐祖马布治疗的含义

Konrad van der Zwet1, Mark Roest2, Dana Huskens2

  • 1Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Research and practice in thrombosis and haemostasis
|January 24, 2025
PubMed
概括

血生成试验不能可靠地预测血患者的出血风险或埃米齐祖马布水平. 这些测试显示出显著的变异性,并且在埃米齐祖马布预防期间与出血事件无关.

关键词:
药物监测 药物监测是指对药物进行监测.艾米奇祖马布 (Emicizumab) 是一种药物.血友病A型 血友病A型 血友病A型一个单克隆抗体.产生血栓的发生.

更多相关视频

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

6.7K
Electrolytic Inferior Vena Cava Model EIM of Venous Thrombosis06:03

Electrolytic Inferior Vena Cava Model EIM of Venous Thrombosis

Published on: July 12, 2011

17.1K

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
603